Authors
Latest:
Pharmacists are Untapped Resource for Reducing Health DisparitiesPharmacists can address the needs of health care consumers earlier in the care journey by building interpersonal relationships and community trust, as well as by leading institutional and public policy reform.
Latest:
The Term 'Bispecific Antibody' Is No Longer EnoughBispecific therapies require clearer terminology to improve safety and communication.
Latest:
Expert Q&A: Expanding the Pharmacist's Role in Community-Based Weight ManagementPharmacists are positioned to significantly impact weight management by offering accessible expertise in medication, lifestyle guidance, and long-term support for healthier choices.
Latest:
Closing Thoughts From The Panel On Pneumococcal VaccinationThe panel of pneumococcal vaccination experts offer their concluding insights and perspectives on the current landscape of pneumococcal vaccines.
Latest:
How Comprehensive Medication Management Improves Patient Outcomes, Health EquityWhen a patient is engaged in the home by a team that includes a pharmacist resource, social determinants of health issues become more clear and the care team can help close the gaps.
Latest:
Building a Sustainable Pharmacogenomics Program: A Pharmacist’s Perspective at Ochsner HealthSerena Mitaly, PharmD, outlines how Ochsner Health is building a sustainable pharmacogenomics program by integrating clinical decision support tools into the EMR, educating providers, addressing reimbursement barriers, and expanding the role of PGx pharmacists in personalized medicine.
Latest:
National Practitioner Data Bank Aims to Reduce MalpracticeGovernment’s database include health care professionals in many categories, including pharmacists.
Latest:
Improving Medication Reconciliation Accuracy in a Primary Care PracticeAccurate medication reconciliations are critical for ensuring safe patient outcomes, and a correct medication list can help prevent drug-drug interactions, contraindications, and duplicate therapies.
Latest:
Research Suggests Alzheimer Disease and Periodontal Disease Are Linked by InflammationPeriodontitis and AD are both characterized by inflammatory and immunological response by the host.
Latest:
Five Years Later: The Case for a COVID-19 Memorial DayLet’s shine the spotlight on ourselves, and let’s begin to heal.
Latest:
Managing Medications at School Is More Than a Family AffairPharmacists can step up counseling and advocate for best practices for children with chronic illnesses.
Latest:
Pharmacist-led Post-Cardiovascular Surgery Outpatient Glycemic ManagementPharmacist-led post-cardiovascular surgery outpatient glycemic management services help reduce hospital readmissions and sternal wound infections in patients with uncontrolled diabetes who recently underwent an interventional cardiology procedure.
Latest:
Fish Oil Supplements are Widely Promoted for Heart Health, But is it Justified?It is important for pharmacists to educate patients, especially those with cardiovascular risks, about the differences between fish oil supplements and prescription n3-FAs products.
Latest:
Looking Ahead: Research Priorities and Final InsightsPanelists discuss how advancing chronic graft-vs-host disease (cGVHD) management involves improving steroid response rates, exploring combination therapies, utilizing biomarkers for personalized treatment, and striving for steroid-free first-line options to enhance patient outcomes and reduce long-term adverse effects.
Latest:
Designing for Safety: The Pharma Industry’s Role in Preventing Medication ErrorsPharmaceutical companies must consider formulation, packaging, and labeling from the start to minimize errors and protect patients.
Latest:
Pharmacists are Overworked, Frustrated, and Unintentionally Absent from Patient Care: It’s Time to Rightsize the RoleSpecialty pharmacists—those caring for patients with serious, sometimes life-threatening conditions such as cancer or rheumatologic disease—are not immune from the ongoing labor crisis.
Latest:
Exploring the Antidepressant Potential of GLP-1 Receptor AgonistsGLP-1 receptor agonists show promise in alleviating depressive symptoms in patients with type 2 diabetes, offering a potential dual benefit in treatment.
Latest:
Implementation of a Pharmacist-Led COPD Transitions of Care ServiceA pharmacist-led transitions of care program reduced chronic obstructive pulmonary disease readmissions by implementing guideline-based inhaler prescribing and addressing medication adherence barriers, decreasing 30-day readmission rates.
Latest:
Preventive Biologics May Aid the Antibiotic Resistance CrisisNew technology and innovation may help turn the corner on antibiotic resistance.
Latest:
AAN 2025: Pharmacists Play Critical Role in Monitoring, Managing Lecanemab TherapyPhilip Kuball, MD, neurology resident at NYU Langone Health, highlights the integral role of pharmacists in monitoring patient eligibility, managing dosing schedules, and ensuring safe medication interactions for lecanemab treatment in Alzheimer disease.
Latest:
Pharmacy Automation Is Critical to Win the Fight Against COVID-19Technology is key in supporting and freeing up time for pharmacists to meet vaccination efforts and increased demands in providing community care.
Latest:
Review of 3 Alternative Pathways to Access Non–FDA-Approved DrugsNon–FDA-approved medications may be accessed for patient care via 3 alternative pathways: expanded access, the Right to Try Act, and off-label use, which are reviewed in this article.
Latest:
Insights Into Small and Rural Hospital Pharmacy PracticeSmall and/or rural hospitals present a great opportunity for self-development and actualization.
Latest:
The Role of Pharmacists and Prescription Monitoring Programs in Stemming the Opioid EpidemicPharmacists can be instrumental in reducing the main challenges in opioid use disorder—namely supply, demand, and harm.
Latest:
Drug Shortages and Alternative Sourcing OpportunitiesAll stakeholders across the drug supply chain must work together to develop and support proactive strategies, creating resilience across the health care ecosystem to avoid and mitigate shortages.
Latest:
Expert: Inadequate Treatment Response, High Costs Common Challenges With IVIG Therapy in CIDPIntravenous immunoglobulin therapy for patients with CIDP requires navigating insurance coverage and prolonged therapy.
